Scholars@Duke
Richard Francis Riedel

Richard Francis Riedel

Professor of Medicine
Medicine, Medical Oncology
richard.riedel@duke.edu
Duke Box 3198, Durham, NC 27710
Dept of Medicine, 25178 Morris Bldg, Durham, NC 27710

Overview

Novel therapies for soft tissue and bone sarcomas

Current Appointments & Affiliations

Professor of Medicine · 2024 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2000 - Present Duke Cancer Institute, Institutes and Centers

In the News

Published March 4, 2015
Dr. Richard Riedel: Early palliative care can cut hospital re-admissions for cancer patients
Published November 7, 2014
Duke revolutionizes cancer care, garners national attention
Published October 22, 2014
Early Palliative Care Can Cut Hospital Readmissions for Cancer Patients

View All News

Recent Publications

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.

Journal Article J Clin Oncol · December 2025 In the phase III placebo-controlled DeFi trial (ClinicalTrials.gov identifier: NCT03785964) primary analysis, nirogacestat showed significant improvement versus placebo in progression-free survival (PFS), objective response rate (ORR), and patient-reported ... Full text Link to item Cite

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032.

Journal Article medRxiv · November 4, 2025 The addition of pembrolizumab to preoperative radiotherapy (RT) improved disease-free survival (DFS) for patients with stage III undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS) in the randomized SU2C-SARC032 tr ... Full text Link to item Cite
View All Publications

Recent Grants


View All Grants

Education, Training & Certifications

Thomas Jefferson University · 2000 M.D.